Search Results - Margunato-Debay, Sandra

  • Showing 1 - 10 results of 10
Refine Results
  1. 1
    nab‐Paclitaxel plus gemcitabine in metastatic pancreatic adenocarcinoma: Australian subset analyses of the phase III MPACT trial

    nab‐Paclitaxel plus gemcitabine in metastatic pancreatic adenocarcinoma: Australian subset analyses of the phase III MPACT trial by Young, Rosemary, Mainwaring, Paul, Clingan, Philip, Parnis, Francis Xavier, Asghari, Gholamreza, Beale, Philip, Aly, Abdalla, Botteman, Marc, Romano, Alfredo, Ferrara, Stefano, Margunato‐Debay, Sandra, Harris, Marion

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Performance status dynamics during treatment with nab -paclitaxel plus gemcitabine versus gemcitabine alone for metastatic pancreatic cancer

    Performance status dynamics during treatment with nab -paclitaxel plus gemcitabine versus gemcitabine alone for metastatic pancreatic cancer by Chiorean, E Gabriela, Von Hoff, Daniel, Wan, Yin, Margunato-Debay, Sandra, Botteman, Marc, Goldstein, David

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Comparative effectiveness and safety of nab -paclitaxel plus carboplatin vs gemcitabine plus carboplatin in first-line treatment of advanced squamous cell non-small cell lung cancer in a US community oncology setting

    Comparative effectiveness and safety of nab -paclitaxel plus carboplatin vs gemcitabine plus carboplatin in first-line treatment of advanced squamous cell non-small cell lung cance... by Mudad, Raja, Patel, Manish B, Margunato-Debay, Sandra, Garofalo, David, Lal, Lincy S

    Published in Lung cancer (Auckland)
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    The Burden of Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL): A Systematic Literature Review (SLR)

    The Burden of Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL): A Systematic Literature Review (SLR) by Lenz, Georg, Rutherford, Sarah C., Davies, Andrew, Zinzani, Pier Luigi, Salles, Gilles, Hasskarl, Jens, Margunato-Debay, Sandra, Rodrigues, Filipe, Nientker, Lisette, Balradj, Janita, Alleman, Cathelijne

    Published in Blood
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    Quality of Life Was Not Negatively Impacted By the Addition of Lenalidomide to R-CHOP Chemotherapy (R2-CHOP) Compared with Placebo Plus R-CHOP Chemotherapy in Patients with Previously Untreated Activated B-Cell (ABC)-Type Diffuse Large B-Cell Lymphoma (DLBCL): Health-Related Quality of Life (HRQoL) Analysis of the International Robust Study

    Quality of Life Was Not Negatively Impacted By the Addition of Lenalidomide to R-CHOP Chemotherapy (R2-CHOP) Compared with Placebo Plus R-CHOP Chemotherapy in Patients with Previou... by Chiappella, Annalisa, Witzig, Thomas E., Cocks, Kim, Greenwood, Mike, Williams, Abi, Scott, David W., Gascoyne, Randy D., Yamamoto, Kazuhito, Jurczak, Wojciech, Özcan, Muhit, Belada, David, Bergua Burgues, Juan Miguel, Piazza, Francesco, Visco, Carlo, Musuraca, Gerardo, Margunato-Debay, Sandra, Czuczman, Myron, Zhai, Merry, Braverman, Julia, Vitolo, Umberto, Nowakowski, Grzegorz

    Published in Blood
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Quality-Adjusted Survival With nab-Paclitaxel Versus Standard Paclitaxel in Metastatic Breast Cancer: A Q-TWiST Analysis

    Quality-Adjusted Survival With nab-Paclitaxel Versus Standard Paclitaxel in Metastatic Breast Cancer: A Q-TWiST Analysis by Cortes, Javier, Pérez-García, José, Whiting, Scott, Wan, Yin, Solem, Caitlyn, Tai, Ming-Hui, Margunato-Debay, Sandra, Ko, Amy, Fandi, Abderrahim, Botteman, Marc

    Published in Clinical breast cancer
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  7. 7
    Quality-adjusted Outcomes Stratified by Response in Patients With Advanced Non–Small-cell Lung Cancer Receiving First-line nab-Paclitaxel/Carboplatin or Paclitaxel/Carboplatin

    Quality-adjusted Outcomes Stratified by Response in Patients With Advanced Non–Small-cell Lung Cancer Receiving First-line nab-Paclitaxel/Carboplatin or Paclitaxel/Carboplatin by Hirsh, Vera, Wan, Yin, Lin, Fang-Ju, Margunato-Debay, Sandra, Ong, Teng Jin, Botteman, Marc, Langer, Corey

    Published in Clinical lung cancer
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  8. 8
    Comparative Effectiveness and Resource Usage in Patients Receiving First-line Taxane-based Chemotherapy for Stage IV Non–Small-cell Lung Cancer in a US Community Oncology Setting

    Comparative Effectiveness and Resource Usage in Patients Receiving First-line Taxane-based Chemotherapy for Stage IV Non–Small-cell Lung Cancer in a US Community Oncology Setting by Weiss, Jared, Force, Rex W., Pugmire, Brook A., Peterson, Teri, Faria, Claudio, Margunato-Debay, Sandra, Patel, Manish B.

    Published in Clinical lung cancer
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  9. 9
    Comparative Effectiveness and Resource Utilization in Patients Receiving First-Line Taxane-Based Chemotherapy for Stage IV Non-Small Cell Lung Cancer in a US Community Oncology Setting

    Comparative Effectiveness and Resource Utilization in Patients Receiving First-Line Taxane-Based Chemotherapy for Stage IV Non-Small Cell Lung Cancer in a US Community Oncology Set... by Weiss, Jared, Force, Rex W, Pugmire, Brook A, Peterson, Teri, Faria, Claudio, Margunato-Debay, Sandra, Patel, Manish B

    Published in Clinical lung cancer
    Get full text
    Article
    Save to List
    Saved in:
  10. 10
    Comparative effectiveness and safety of nab-paclitaxel plus carboplatin vs gemcitabine plus carboplatin in first-line treatment of advanced squamous cell non-small cell lung cancer in a US community oncology setting

    Comparative effectiveness and safety of nab-paclitaxel plus carboplatin vs gemcitabine plus carboplatin in first-line treatment of advanced squamous cell non-small cell lung cancer... by Mudad, Raja, Patel, Manish B, Margunato-Debay, Sandra, Garofalo, David, Lal, Lincy S

    Published in Lung cancer (Auckland)
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: